Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Times Interest Earned (2016 - 2019)

Fate Therapeutics' Times Interest Earned history spans 7 years, with the latest figure at -$48.46 for Q4 2019.

  • For Q4 2019, Times Interest Earned fell 25.64% year-over-year to -$48.46; the TTM value through Sep 2020 reached -$206.27, down 284.59%, while the annual FY2019 figure was -$55.96, 41.79% down from the prior year.
  • Times Interest Earned reached -$48.46 in Q4 2019 per FATE's latest filing, up from -$67.8 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$11.26 in Q3 2015 to a low of -$67.8 in Q3 2019.
  • Average Times Interest Earned over 5 years is -$33.77, with a median of -$34.11 recorded in 2018.
  • Peak YoY movement for Times Interest Earned: surged 94.06% in 2015, then plummeted 131.08% in 2017.
  • A 5-year view of Times Interest Earned shows it stood at -$11.26 in 2015, then crashed by 106.62% to -$23.26 in 2016, then dropped by 27.74% to -$29.72 in 2017, then fell by 29.8% to -$38.57 in 2018, then dropped by 25.64% to -$48.46 in 2019.
  • Per Business Quant, the three most recent readings for FATE's Times Interest Earned are -$48.46 (Q4 2019), -$67.8 (Q3 2019), and -$58.89 (Q2 2019).